Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial von Creelan, Benjamin C., Wang, Chao, Teer, Jamie K., Toloza, Eric M., Yao, Jiqiang, Kim, Sungjune, Landin, Ana M., Mullinax, John E., Saller, James J., Saltos, Andreas N., Noyes, David R., Montoya, Leighann B., Curry, Wesley, Pilon-Thomas, Shari A., Chiappori, Alberto A., Tanvetyanon, Tawee, Kaye, Frederic J., Thompson, Zachary J., Yoder, Sean J., Fang, Bin, Koomen, John M., Sarnaik, Amod A., Chen, Dung-Tsa, Conejo-Garcia, Jose R., Haura, Eric B., Antonia, Scott J.

Volltext

The Microeconomics of Efficient Group Behavior: Identification von Chiappori, P.-A., Ekeland, I.

Volltext

A randomized phase II study of the telomerase inhibitor imetelstat as maintenance therapy for advanced non-small-cell lung cancer von Chiappori, A.A., Kolevska, T., Spigel, D.R., Hager, S., Rarick, M., Gadgeel, S., Blais, N., Von Pawel, J., Hart, L., Reck, M., Bassett, E., Burington, B., Schiller, J.H.

Volltext

Testing Mixed-Strategy Equilibria When Players Are Heterogeneous: The Case of Penalty Kicks in Soccer von P.-A. Chiappori, Levitt, S., Groseclose, T.

Volltext

Safety and activity of alectinib against systemic disease and brain metastases in patients with crizotinib-resistant ALK -rearranged non-small-cell lung cancer (AF-002JG): results... von Gadgeel, Shirish M, MD, Gandhi, Leena, MD, Riely, Gregory J, MD, Chiappori, Alberto A, MD, West, Howard L, MD, Azada, Michele C, MPH, Morcos, Peter N, PharmD, Lee, Ruey-Min, MD, Garcia, Linta, PharmD, Yu, Li, PhD, Boisserie, Frederic, MSc, Di Laurenzio, Laura, PhD, Golding, Sophie, MSc, Sato, Jotaro, MS, Yokoyama, Shumpei, MS, Tanaka, Tomohiro, MS, Ou, Sai-Hong Ignatius, Dr

Volltext

Estimating Consumption Economies of Scale, Adult Equivalence Scales, and Household Bargaining Power von BROWNING, MARTIN, CHIAPPORI, PIERRE-ANDRÉ, LEWBEL, ARTHUR

Volltext

Efficient Intra-Household Allocations: A General Characterization and Empirical Tests von Browning, M., Chiappori, P. A.

Volltext

Utilization of target lesion heterogeneity for treatment efficacy assessment in late stage lung cancer von Chen, Dung-Tsa, Chan, Wenyaw, Thompson, Zachary J., Thapa, Ram, Beg, Amer A., Saltos, Andreas N., Chiappori, Alberto A., Gray, Jhanelle E., Haura, Eric B., Rose, Trevor A., Creelan, Ben

Volltext

Temporal trends from 1986 to 2008 in overall survival of small cell lung cancer patients von Schabath, Matthew B, Nguyen, Anthony, Wilson, Patrick, Sommerer, Katelyn R, Thompson, Zachary J, Chiappori, Alberto A

Volltext

Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker von Munster, P N, Marchion, D, Thomas, S, Egorin, M, Minton, S, Springett, G, Lee, J-H, Simon, G, Chiappori, A, Sullivan, D, Daud, A

Volltext

First-in-human study of an OX40 (ivuxolimab) and 4-1BB (utomilumab) agonistic antibody combination in patients with advanced solid tumors von Hamid, Omid, Chiappori, Alberto A, Thompson, John A, Doi, Toshihiko, Hu-Lieskovan, Siwen, Eskens, Ferry A L M, Ros, Willeke, Diab, Adi, Spano, Jean-Philippe, Rizvi, Naiyer A, Wasser, Jeffrey S, Angevin, Eric, Ott, Patrick A, Forgie, Alison, Yang, Wenjing, Guo, Cen, Chou, Jeffrey, El-Khoueiry, Anthony B

Volltext

Variance of SUVs for FDG-PET/CT is Greater in Clinical Practice Than Under Ideal Study Settings von Kumar, Virendra, Nath, Kavindra, Berman, Claudia G, Kim, Jongphil, Tanvetyanon, Tawee, Chiappori, Alberto A, Gatenby, Robert A, Gillies, Robert J, Eikman, Edward A

Volltext

A phase I trial of pan-Bcl-2 antagonist obatoclax administered as a 3-h or a 24-h infusion in combination with carboplatin and etoposide in patients with extensive-stage small cell... von Chiappori, A A, Schreeder, M T, Moezi, M M, Stephenson, J J, Blakely, J, Salgia, R, Chu, Q S, Ross, H J, Subramaniam, D S, Schnyder, J, Berger, M S

Volltext

Unveiling the Molecular Features of SCLC With a Clinical RNA Expression Panel von Ozakinci, Hilal, Alontaga, Aileen Y., Cano, Pedro, Koomen, John M., Perez, Bradford A., Beg, Amer A., Chiappori, Alberto A., Haura, Eric B., Boyle, Theresa A.

Volltext

Phase I Trial of Poly-l-Glutamate Camptothecin (CT-2106) Administered Weekly in Patients with Advanced Solid Malignancies von HOMSI, Jade, SIMON, George R, ANGIULI, Patrizia, EISENFELD, Amy, SULLIVAN, Daniel M, DAUD, Adil I, GARRETT, Chris R, SPRINGETT, Gregory, DE CONTI, Ronald, CHIAPPORI, Alberto A, MUNSTER, Pamela N, BURTON, Michelle K, STROMATT, Scott, ALLIEVI, Claudia

Volltext

Omalizumab Modulates Bronchial Reticular Basement Membrane Thickness and Eosinophil Infiltration in Severe Persistent Allergic Asthma Patients von Riccio, A.M., Dal Negro, R.W., Micheletto, C., De Ferrari, L., Folli, C., Chiappori, A., Canonica, G.W.

Volltext

Genetic Investigation of Uterine Carcinosarcoma: Case Report and Cohort Analysis von Hembree, Timothy N, Teer, Jamie K, Hakam, Ardeshir, Chiappori, Alberto A

Volltext

Multicenter, Randomized, Phase II Trial of CI-1033, an Irreversible Pan-ERBB Inhibitor, for Previously Treated Advanced Non–Small-Cell Lung Cancer von JÄNNE, Pasi A, VON PAWEL, Joachim, DASSE, Kathy, SHEERAN, Meredith, BONOMI, Philip D, COHEN, Roger B, CRINO, Lucio, BUTTS, Charles A, OLSON, Steven S, EISEMAN, Irene A, CHIAPPORI, Alberto A, YEAP, Beow Y, LENEHAN, Peter F

Volltext

Clinical Pathway Adherence Improvement: A Quality Engagement Initiative for Lung Cancer von Chiappori, A, Antonia, S, Peabody, J, Kubal, T, Letson, D

Volltext

Phase I Study of Taminadenant (PBF509/NIR178), an Adenosine 2A Receptor Antagonist, with or without Spartalizumab (PDR001), in Patients with Advanced Non-Small Cell Lung Cancer von Chiappori, Alberto A, Creelan, Ben, Tanvetyanon, Tawee, Gray, Jhanelle E, Haura, Eric B, Thapa, Ram, Barlow, Margaret L, Chen, Zhihua, Chen, Dung Tsa, Beg, Amer A, Boyle, Theresa A, Castro, Julio, Morgan, Liza, Morris, Erick, Aregay, Mehreteab, Hurtado, Felipe K, Manenti, Luigi, Antonia, Scott

Volltext